About This Course
This course provides an overview of contemporary strategies in the diagnosis and management of non–small cell lung cancer (NSCLC) with an emphasis on multidisciplinary collaboration. It highlights the importance of presenting early-stage cases at tumor board to ensure that surgical, medical oncology, radiation oncology, pathology, pulmonology, and interventional radiology perspectives are incorporated into individualized treatment planning. Learners explore the growing role of liquid biopsy for detecting circulating tumor DNA, the application of next-generation sequencing to identify actionable mutations, and the expanding use of minimally invasive ablation techniques as lung-sparing options for selected patients. The course also reviews appropriate timelines for post-treatment imaging after neoadjuvant therapy and examines how biomarkers such as PD-L1 expression inform immunotherapy decisions. Collectively, the module underscores how integrated diagnostics, molecular testing, and procedural innovations shape modern NSCLC care.